LGND Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.00%

Insider Buying (Last 12 Months): $1,156,542.00

Insider Selling (Last 12 Months): $3,264,991.97

Ligand Pharmaceuticals Insider Trading History Chart

Ligand Pharmaceuticals Share Price & Price History

^$188.50

▼ -4.53 (-2.35%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Ligand Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/1/2025	John W. Kozarich	Director	Sell	467	$195.84	$91,457.28	44,121
11/3/2025	John W. Kozarich	Director	Sell	467	$191.05	$89,220.35	44,588
10/1/2025	John W. Kozarich	Director	Sell	467	$179.44	$83,798.48	45,055
9/23/2025	Jason Aryeh	Director	Sell	10,000	$170.81	$1,708,100.00	69,289
9/2/2025	John W. Kozarich	Director	Sell	467	$162.26	$75,775.42	45,522
8/1/2025	John W. Kozarich	Director	Sell	467	$131.88	$61,587.96	45,989
7/10/2025	John W. Kozarich	Director	Sell	934	$125.00	$116,750.00	46,456
6/23/2025	Andrew Reardon	Insider	Sell	500	$114.08	$57,040.00	31,903
6/10/2025	Andrew Reardon	Insider	Sell	500	$114.54	$57,270.00	32,403
5/15/2025	Andrew Reardon	Insider	Sell	1,000	$104.00	$104,000.00	32,903
5/9/2025	Octavio Espinoza	CFO	Buy	1,500	$104.06	$156,090.00	27,932
5/9/2025	Todd C. Davis	CEO	Buy	9,510	$105.20	$1,000,452.00	161,234
3/4/2025	Octavio Espinoza	CFO	Sell	5,000	$115.03	$575,150.00	18,879
12/23/2024	Octavio Espinoza	CFO	Sell	2,104	$116.37	$244,842.48	20,647
11/27/2024	John L. LaMattina	Director	Sell	2,406	$123.65	$297,501.90	29,515
9/23/2024	Andrew Reardon	Insider	Sell	2,000	$99.60	$199,200.00	22,534
9/23/2024	Matthew E Korenberg	COO	Sell	9,772	$101.22	$989,121.84	50,777
9/20/2024	Matthew E Korenberg	COO	Sell	6,275	$104.10	$653,227.50	50,777
9/20/2024	Octavio Espinoza	CFO	Sell	1,275	$103.94	$132,523.50	24,610
8/28/2024	Andrew Reardon	Insider	Sell	1,500	$106.39	$159,585.00	22,534
8/26/2024	Matthew E Korenberg	COO	Sell	11,389	$105.61	$1,202,792.29	49,510
8/22/2024	Matthew E Korenberg	COO	Sell	1,157	$105.54	$122,109.78	67,211
8/9/2024	Matthew E Korenberg	COO	Sell	18,245	$98.50	$1,797,132.50	68,368
8/8/2024	Todd C. Davis	CEO	Buy	2,500	$97.39	$243,475.00	123,010
5/17/2024	Octavio Espinoza	CFO	Sell	5,156	$86.66	$446,818.96	23,379
5/15/2024	Octavio Espinoza	CFO	Sell	5,873	$86.01	$505,136.73	23,882
5/13/2024	Matthew E Korenberg	Insider	Sell	3,440	$84.54	$290,817.60	100,421
5/9/2024	Andrew Reardon	Insider	Sell	10,000	$83.04	$830,400.00	22,205
5/9/2024	Nancy Ryan Gray	Director	Sell	934	$83.20	$77,708.80	5,633
3/5/2024	Stephen L. Sabba	Director	Sell	1,893	$74.30	$140,649.90	28,926
2/28/2024	Octavio Espinoza	CFO	Sell	140	$88.46	$12,384.40	29,755
9/22/2023	Todd C. Davis	CEO	Buy	4,000	$59.38	$237,520.00	73,090
5/16/2023	John W. Kozarich	Director	Sell	4,444	$77.20	$343,076.80	38,488
5/10/2023	Stephen L. Sabba	Director	Sell	6,408	$77.13	$494,249.04	25,784
5/8/2023	John W. Kozarich	Director	Sell	6,408	$76.56	$490,596.48	42,213
3/24/2023	Andrew Reardon	Insider	Sell	300	$69.92	$20,976.00	16,308
12/16/2022	John L. Higgins	Director	Sell	10,000	$61.87	$618,700.00	422,984

SEC Filings (Institutional Ownership Changes) for Ligand Pharmaceuticals (NASDAQ:LGND)

91.28% of Ligand Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ligand Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/25/2025	Court Place Advisors LLC	5,158	$0.91M	0.3%	-1.9%	0.026%
11/24/2025	Penn Capital Management Company LLC	107,282	$19.02M	1.5%	-10.9%	0.545%
11/24/2025	CIBC Private Wealth Group LLC	149	$26K	0.0%	+86.3%	0.001%
11/21/2025	CIBC Bancorp USA Inc.	2,034	$0.36M	0.0%	N/A	0.010%
11/20/2025	Wilmington Savings Fund Society FSB	1,082	$0.19M	0.0%	-8.5%	0.005%
11/19/2025	Captrust Financial Advisors	15,009	$2.66M	0.0%	-3.8%	0.076%
11/18/2025	Acuitas Investments LLC	13,494	$2.39M	1.5%	-32.2%	0.069%
11/18/2025	Cim Investment Management Inc.	1,435	$0.25M	0.1%	N/A	0.007%
11/17/2025	Jacobs Levy Equity Management Inc.	127,689	$22.62M	0.1%	-21.6%	0.649%
11/17/2025	Castleark Management LLC	64,676	$11.46M	0.3%	N/A	0.329%
11/17/2025	CANADA LIFE ASSURANCE Co	23,299	$4.03M	0.0%	+1.5%	0.118%
11/17/2025	Caxton Associates LLP	14,508	$2.57M	0.1%	N/A	0.074%
11/17/2025	Verition Fund Management LLC	4,863	$0.86M	0.0%	-65.7%	0.025%
11/17/2025	Susquehanna Fundamental Investments LLC	1,184	$0.21M	0.0%	N/A	0.006%
11/17/2025	Private Capital Management LLC	227,158	$40.24M	3.6%	-0.9%	1.154%
11/17/2025	Qube Research & Technologies Ltd	3,632	$0.64M	0.0%	-79.9%	0.018%
11/17/2025	Nomura Holdings Inc.	121,363	$21.50M	0.0%	N/A	0.617%
11/17/2025	Mariner LLC	1,537	$0.27M	0.0%	N/A	0.008%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	8,869	$1.57M	0.0%	-15.2%	0.045%
11/17/2025	JPL Wealth Management LLC	296	$52K	0.0%	N/A	0.002%
11/17/2025	Gotham Asset Management LLC	9,475	$1.68M	0.0%	N/A	0.048%
11/17/2025	Granahan Investment Management LLC	24,962	$4.42M	0.2%	N/A	0.127%
11/17/2025	Fred Alger Management LLC	5,868	$1.04M	0.0%	N/A	0.030%
11/17/2025	Clark Capital Management Group Inc.	82,991	$14.70M	0.1%	+16.7%	0.422%
11/17/2025	Bank of America Corp DE	122,409	$21.68M	0.0%	+5.7%	0.622%
11/17/2025	Aquatic Capital Management LLC	6,598	$1.17M	0.0%	N/A	0.034%
11/17/2025	Alliancebernstein L.P.	22,253	$3.94M	0.0%	+7.6%	0.113%
11/17/2025	Ameriprise Financial Inc.	101,243	$17.93M	0.0%	-7.7%	0.514%
11/14/2025	Creative Planning	6,112	$1.08M	0.0%	+28.7%	0.031%
11/14/2025	Ashford Capital Management Inc.	244,430	$43.30M	4.8%	-19.2%	1.242%
11/14/2025	Raymond James Financial Inc.	18,860	$3.34M	0.0%	-6.2%	0.096%
11/14/2025	Amundi	3,356	$0.61M	0.0%	+7.3%	0.017%
11/14/2025	Equitable Holdings Inc.	8,836	$1.57M	0.0%	+26.1%	0.045%
11/14/2025	California State Teachers Retirement System	18,311	$3.24M	0.0%	-4.1%	0.093%
11/14/2025	Zurcher Kantonalbank Zurich Cantonalbank	3,193	$0.57M	0.0%	+27.5%	0.016%
11/14/2025	Fiduciary Trust Co	1,698	$0.30M	0.0%	N/A	0.009%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	376,601	$66.71M	0.0%	-3.9%	1.913%
11/14/2025	Squarepoint Ops LLC	17,897	$3.17M	0.0%	N/A	0.091%
11/14/2025	Comerica Bank	6,535	$1.16M	0.0%	-14.5%	0.033%
11/14/2025	F m Investments LLC	51,476	$9.12M	0.4%	-2.0%	0.263%
11/14/2025	Glenmede Investment Management LP	4,739	$0.84M	0.0%	N/A	0.024%
11/13/2025	Martingale Asset Management L P	18,472	$3.27M	0.1%	-8.3%	0.094%
11/13/2025	Invesco Ltd.	378,295	$67.01M	0.0%	+64.6%	1.930%
11/13/2025	Sei Investments Co.	27,424	$4.86M	0.0%	+28.1%	0.140%
11/13/2025	UBS Group AG	111,986	$19.84M	0.0%	+234.2%	0.571%
11/13/2025	BNP Paribas Financial Markets	4,092	$0.73M	0.0%	+95.2%	0.021%
11/13/2025	Mackenzie Financial Corp	1,169	$0.21M	0.0%	N/A	0.006%
11/13/2025	Franklin Resources Inc.	229,856	$40.72M	0.0%	+23.5%	1.173%
11/13/2025	Bank of Montreal Can	125,769	$22.28M	0.0%	+2,096.5%	0.642%
11/13/2025	Legal & General Group Plc	108,370	$19.20M	0.0%	-8.4%	0.553%
11/13/2025	Swiss National Bank	37,400	$6.63M	0.0%	+1.6%	0.191%
11/13/2025	Russell Investments Group Ltd.	136,130	$24.11M	0.0%	-6.5%	0.695%
11/13/2025	Blair William & Co. IL	8,386	$1.49M	0.0%	+8.9%	0.043%
11/13/2025	First Trust Advisors LP	51,688	$9.16M	0.0%	+5.8%	0.264%
11/12/2025	Barclays PLC	30,283	$5.36M	0.0%	-22.3%	0.155%
11/12/2025	Orion Porfolio Solutions LLC	1,186	$0.21M	0.0%	N/A	0.006%
11/12/2025	GW&K Investment Management LLC	32,135	$5.69M	0.1%	-3.9%	0.164%
11/12/2025	Dimensional Fund Advisors LP	523,913	$92.80M	0.0%	-25.6%	2.673%
11/12/2025	Legato Capital Management LLC	16,297	$2.89M	0.3%	+40.5%	0.083%
11/12/2025	Victory Capital Management Inc.	254,805	$45.14M	0.0%	+676.6%	1.300%
11/12/2025	Fisher Asset Management LLC	108,926	$19.30M	0.0%	+2.7%	0.556%
11/12/2025	Rafferty Asset Management LLC	1,303	$0.23M	0.0%	N/A	0.007%
11/12/2025	Xponance Inc.	1,499	$0.27M	0.0%	N/A	0.008%
11/12/2025	Choreo LLC	1,618	$0.29M	0.0%	N/A	0.008%
11/12/2025	Intech Investment Management LLC	6,112	$1.08M	0.0%	-20.4%	0.031%
11/12/2025	US Bancorp DE	1,396	$0.25M	0.0%	-63.0%	0.007%
11/10/2025	Dana Investment Advisors Inc.	72,659	$12.87M	0.4%	-0.7%	0.371%
11/10/2025	Cornerstone Capital Inc.	5,187	$0.92M	0.1%	-9.6%	0.026%
11/10/2025	Equitable Trust Co.	5,915	$1.05M	0.0%	-5.3%	0.030%
11/10/2025	Granite Investment Partners LLC	61,620	$10.92M	0.6%	-50.5%	0.314%
11/10/2025	Ameritas Investment Partners Inc.	1,594	$0.28M	0.0%	-18.2%	0.008%
11/10/2025	Citigroup Inc.	21,387	$3.79M	0.0%	-27.9%	0.109%
11/10/2025	Isthmus Partners LLC	29,498	$5.23M	1.2%	-20.9%	0.151%
11/10/2025	China Universal Asset Management Co. Ltd.	3,435	$0.61M	0.1%	-11.4%	0.018%
11/7/2025	CenterBook Partners LP	6,434	$1.14M	0.1%	-52.2%	0.033%
11/7/2025	Vanguard Group Inc.	2,076,283	$367.79M	0.0%	-0.6%	10.595%
11/7/2025	JPMorgan Chase & Co.	39,718	$7.04M	0.0%	+4.5%	0.203%
11/7/2025	State of New Jersey Common Pension Fund D	13,521	$2.40M	0.0%	N/A	0.069%
11/7/2025	PNC Financial Services Group Inc.	1,830	$0.32M	0.0%	+10.5%	0.009%
11/7/2025	Aberdeen Group plc	189,748	$33.61M	0.1%	-17.2%	0.968%
11/7/2025	GF Fund Management CO. LTD.	422	$75K	0.0%	-12.8%	0.002%
11/6/2025	BTC Capital Management Inc.	2,996	$0.53M	0.0%	-12.5%	0.015%
11/6/2025	Cookson Peirce & Co. Inc.	9,763	$1.73M	0.1%	+1.9%	0.050%
11/6/2025	Public Sector Pension Investment Board	76,444	$13.54M	0.0%	+16.2%	0.390%
11/6/2025	Illinois Municipal Retirement Fund	9,821	$1.74M	0.0%	+8.6%	0.050%
11/6/2025	Wedbush Securities Inc.	1,133	$0.20M	0.0%	N/A	0.006%
11/6/2025	Cornerstone Investment Partners LLC	1,697	$0.30M	0.0%	-7.0%	0.009%
11/6/2025	Cibc World Market Inc.	59,131	$10.47M	0.0%	+11.7%	0.302%
11/6/2025	Rhumbline Advisers	59,422	$10.53M	0.0%	-0.1%	0.303%
11/6/2025	Impax Asset Management Group plc	200,208	$35.47M	0.2%	-23.1%	1.022%
11/6/2025	Advisors Asset Management Inc.	3,403	$0.60M	0.0%	-3.7%	0.017%
11/6/2025	Baader Bank Aktiengesellschaft	2,062	$0.36M	0.0%	N/A	0.011%
11/6/2025	Essex Investment Management Co. LLC	61,142	$10.83M	1.7%	+0.5%	0.312%
11/6/2025	Profund Advisors LLC	2,653	$0.47M	0.0%	+9.0%	0.014%
11/6/2025	ProShare Advisors LLC	4,301	$0.76M	0.0%	-13.7%	0.022%
11/5/2025	Smartleaf Asset Management LLC	271	$47K	0.0%	+31.6%	0.001%
11/5/2025	Ranger Investment Management L.P.	275,340	$48.77M	3.4%	-8.2%	1.405%
11/5/2025	Portside Wealth Group LLC	4,218	$0.75M	0.1%	+20.8%	0.022%
11/5/2025	Bessemer Group Inc.	746	$0.13M	0.0%	+1,013.4%	0.004%
11/5/2025	Envestnet Asset Management Inc.	31,915	$5.65M	0.0%	+16.6%	0.163%

Data available starting January 2016

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, engages in the development and licensing of biopharmaceutical assets worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; Filspari, a dual endothelin and angiotensin II receptor antagonist in development for rare kidney diseases and non-immunosuppressive treatment indicated for immunoglobulin A nephropathy; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by streptococcus pneumoniae serotypes; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and children aged 8 years and older with Stage 2 T1D; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression; and Veklury, an antiviral treatment for moderate or severe COVID-19. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of post-menopausal symptoms in women; Exemptia for autoimmune diseases; Vivitra for breast cancer; and Bryxta and Zybev for various indications. The company has alliances, licenses, and other business relationships with Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences, and Baxter International. Further, it sells Captisol materials. Ligand Pharmaceuticals Incorporated was incorporated in 1987 and is based in Jupiter, Florida.

Today's Range

Now: $188.50

$187.87

$194.90

50 Day Range

MA: $191.39

$169.72

$209.29

52 Week Range

Now: $188.50

$93.58

$212.49

Volume

194,343 shs

Average Volume

226,796 shs

Market Capitalization

$3.71 billion

P/E Ratio

91.06

Dividend Yield

N/A

Beta

0.99

Who are the company insiders with the largest holdings of Ligand Pharmaceuticals?: Ligand Pharmaceuticals' top insider investors include:
Todd C Davis (CEO)
Matthew E Korenberg (Insider)
Jason Aryeh (Director)
Matthew E Korenberg (COO)
John W Kozarich (Director)
Andrew Reardon (Insider)
Octavio Espinoza (CFO)
John L Lamattina (Director)
Stephen L Sabba (Director)
Nancy Ryan Gray (Director)
Learn More about top insider investors at Ligand Pharmaceuticals.
Who are the major institutional investors of Ligand Pharmaceuticals?: Ligand Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 10.59%
Congress Asset Management Co. — 3.40%
Chicago Capital LLC — 2.90%
Stephens Investment Management Group LLC — 2.83%
Massachusetts Financial Services Co. MA — 2.76%
Dimensional Fund Advisors LP — 2.67%
Learn More about top institutional investors of Ligand Pharmaceuticals stock.
Which institutional investors are selling Ligand Pharmaceuticals stock?: In the previous quarter, LGND stock was sold by these institutional investors:
Dimensional Fund Advisors LP
Granite Investment Partners LLC
Impax Asset Management Group plc
Ashford Capital Management Inc.
Stephens Investment Management Group LLC
Rice Hall James & Associates LLC
Aberdeen Group plc
Jacobs Levy Equity Management Inc.
During the previous year, company insiders that have sold Ligand Pharmaceuticals company stock include:
Todd C Davis (CEO)
Matthew E Korenberg (Insider)
Jason Aryeh (Director)
Matthew E Korenberg (COO)
Learn More investors selling Ligand Pharmaceuticals stock.
Which institutional investors are buying Ligand Pharmaceuticals stock?: During the previous quarter, LGND stock was acquired by institutional investors including:
Acuitas Investments LLC
Victory Capital Management Inc.
Massachusetts Financial Services Co. MA
Invesco Ltd.
Nomura Holdings Inc.
Bank of Montreal Can
UBS Group AG
Castleark Management LLC
Within the last year, these company insiders have bought Ligand Pharmaceuticals stock:
Todd C Davis (CEO)
Matthew E Korenberg (Insider)
Learn More investors buying Ligand Pharmaceuticals stock.